BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 33570039)

  • 1. [SARS-CoV-2 and neurological disorders: the revelance of biomarkers?].
    Bigot-Corbel E; Lanore A; Raulet C; Delorme C; Azulay JP; Lehmann S; Beaudeux JL; Beauvieux MC; Sapin V; Peoc'h K; Rucheton B;
    Ann Biol Clin (Paris); 2021 Feb; 79(1):7-16. PubMed ID: 33570039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature.
    Siracusa L; Cascio A; Giordano S; Medaglia AA; Restivo GA; Pirrone I; Saia GF; Collura F; Colomba C
    Ital J Pediatr; 2021 Jun; 47(1):123. PubMed ID: 34078441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological Involvements of SARS-CoV2 Infection.
    Gasmi A; Tippairote T; Mujawdiya PK; Gasmi Benahmed A; Menzel A; Dadar M; Bjørklund G
    Mol Neurobiol; 2021 Mar; 58(3):944-949. PubMed ID: 33064267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does COVID-19 contribute to development of neurological disease?
    Mahalakshmi AM; Ray B; Tuladhar S; Bhat A; Paneyala S; Patteswari D; Sakharkar MK; Hamdan H; Ojcius DM; Bolla SR; Essa MM; Chidambaram SB; Qoronfleh MW
    Immun Inflamm Dis; 2021 Mar; 9(1):48-58. PubMed ID: 33332737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.
    Román GC; Spencer PS; Reis J; Buguet A; Faris MEA; Katrak SM; Láinez M; Medina MT; Meshram C; Mizusawa H; Öztürk S; Wasay M;
    J Neurol Sci; 2020 Jul; 414():116884. PubMed ID: 32464367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.
    Montalvan V; Lee J; Bueso T; De Toledo J; Rivas K
    Clin Neurol Neurosurg; 2020 Jul; 194():105921. PubMed ID: 32422545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological complications in COVID-19 - a diagnostic challenge.
    Vacaras V; Frunze S; Cordos AM
    J Med Life; 2021; 14(2):216-224. PubMed ID: 34104245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological Associations of SARS-CoV-2 Infection: A Systematic Review.
    Javed A
    CNS Neurol Disord Drug Targets; 2022; 21(3):246-258. PubMed ID: 33593267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection.
    Xu Y; Zhuang Y; Kang L
    Med Sci Monit; 2021 Jun; 27():e932962. PubMed ID: 34145211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond.
    Mussa BM; Srivastava A; Verberne AJM
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does SARS-CoV-2 infection cause chronic neurological complications?
    Hascup ER; Hascup KN
    Geroscience; 2020 Aug; 42(4):1083-1087. PubMed ID: 32451846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nervous system-A new territory being explored of SARS-CoV-2.
    Zhang M; Zhou L; Wang J; Wang K; Wang Y; Pan X; Ma A
    J Clin Neurosci; 2020 Dec; 82(Pt A):87-92. PubMed ID: 33317745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological complications of COVID-19: a systematic review.
    Taherifard E; Taherifard E
    Neurol Res; 2020 Nov; 42(11):905-912. PubMed ID: 32698732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19: dealing with a potential risk factor for chronic neurological disorders.
    Schirinzi T; Landi D; Liguori C
    J Neurol; 2021 Apr; 268(4):1171-1178. PubMed ID: 32852580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus].
    Bereczki D; Stang R; Böjti P; Kovács T
    Ideggyogy Sz; 2020 May; 73(05-06):171-175. PubMed ID: 32579306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurologic manifestations associated with COVID-19: a multicentre registry.
    Meppiel E; Peiffer-Smadja N; Maury A; Bekri I; Delorme C; Desestret V; Gorza L; Hautecloque-Raysz G; Landre S; Lannuzel A; Moulin S; Perrin P; Petitgas P; SellaI F; Wang A; Tattevin P; de Broucker T;
    Clin Microbiol Infect; 2021 Mar; 27(3):458-466. PubMed ID: 33189873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological manifestations in coronavirus disease 2019.
    Corona T; Rodríguez-Violante M; Delgado-García G
    Gac Med Mex; 2020; 156(4):317-320. PubMed ID: 32831319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological manifestations of COVID-19: A brief review.
    Sachdev K; Agrawal S; Ish P; Gupta N; Raheja K
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):41-47. PubMed ID: 32859864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.